You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
10 November 2026 - French vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Tuesday reported sustained antibody responses five years after a single dose of its chikungunya vaccine, IXCHIQ, with 94% of 221 evaluable participants maintai...
10 November 2026 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Tuesday that it has received US Food and Drug Administration (FDA) 510(k) clearance and European IVDR CE marking for VITEK PRO, its new automated microb...
10 November 2026 - Energenesis Biomedical Co Ltd (TWSE:6657), a clinical-stage biopharmaceutical company focused on restoring cellular energy, announced on Monday that it presented at the Taiwan Space International Conference & Industry Expo (TAS...
9 November 2026 - Biopharmaceutical company Janux Therapeutics Inc (Nasdaq: JANX) on Monday reported positive initial Phase 1 results for JANX011 in healthy volunteers, supporting plans to advance the investigational therapy into clinical studies for...
9 November 2026 - Genome research company Illumina Inc (NASDAQ: ILMN) announced on Monday that it has expanded its molecular residual disease (MRD) research portfolio with an early access programme for a new ultrasensitive duplex sequencing workflow ...
9 November 2026 - French vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Monday announced positive results from two Phase 2 trials of S4V2, its tetravalent bioconjugate vaccine candidate targeting shigellosis.The studies demonstrated...
9 November 2026 - Diagnostic company Photocure ASA (OSE: PHO) confirmed on Monday that the anticipated Medicare coverage timeline for its AssureMDx bladder cancer test remains aligned with its original acquisition assumptions, following a newly publi...